PolysacDB Capsular polysaccharide 2642

From DrugPedia: A Wikipedia for Drug discovery

Revision as of 06:14, 8 April 2010 by Raghavagps (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search


Contents

Carbohydrate Name

Capsular polysaccharide

Carbohydrate Class

Capsular polysaccharide

Source Microbe

Cryptococcus neoformans Serotype D

Basic Structure

This polysaccharide is a high m.w. polymer with a linear α-(1-->3)-linked mannose backbone that is substituted with non-reducing D-xyIosyal and D-glucosyluronic acid groups. O-Acetylation varies with the serotype. Type D is the most heavily O-acetylated


Proposed functions

Antiphagocytic ; an important virulence factor

Antigenic Nature used to produce antibodies

Glycoconjugates

Carrier Name

Methylated bovine serum albumin

Conjugation Method

A saline solution containing 500 pg of cryptococcal polysaccharide was mixed with 500 pg aqueous methylated bovine serum albumin. The volume was brought to 2 ml with sterile distilled water

Antibodies

Polysera

Antibody type and class

IgG

Assay System

Antiserum to untreated cryptococcal polysaccharide was enriched for O-acetyl and carboxyl specific antibody respectively. The antisera was then used in ouchterlony double diffusion.

Cross-reactivity

N/A

Proposed epitopes

N/A

Proposed Utility

O-acetyl and carboxyl groups are strong and distinct physicochemical determinants on cryptococcal polysaccharide. The enriched antiserum displayed a level of opsonic activity that was similar to non-enriched antiserum. This showed that neither O-acetyl nor carboxyl groups were responsible for inhibition of phagocytosis by cryptococcal polysaccharide

Weblink

PubMed

External Links